Genedrive (GDR) RNS Announcements
Add to Alert list| Date | Time | Source | Announcement |
|---|---|---|---|
| 20 Nov 2007 | 03:32 PM | Issue of Equity | |
| 02 Nov 2007 | 08:56 AM | Notifiable Interest | |
| 02 Nov 2007 | 08:41 AM | Notice of AGM | |
| 23 Oct 2007 | 10:15 AM | Director/PDMR Shareholding | |
| 10 Oct 2007 | 07:01 AM | Preliminary Results | |
| 20 Sep 2007 | 10:24 AM | EpiStem Successfully Complete First Year Of Muc... | |
| 20 Sep 2007 | 07:01 AM | Research Update | |
| 17 Aug 2007 | 09:57 AM | AIM Rule 26 | |
| 31 Jul 2007 | 07:01 AM | Trading Update | |
| 28 Jun 2007 | 02:16 PM | Directors Shareholdings | |
| 22 May 2007 | 07:30 AM | Research Update | |
| 04 Apr 2007 | 08:00 AM | Admission to AIM |
Genedrive plc is a medical equipment company based in Manchester, UK that develops and sells point-of-care molecular diagnostic platforms. Their products are used in healthcare settings, particularly in emergency medicine, for patient stratification and disease detection. Genedrive's goal is to improve clinical outcomes with easy-to-use tests.
Genedrive's major products include:
Genedrive CYP2C19 ID Kit: A rapid test that establishes metaboliser status in time-critical settings
Genedrive MT-RNR1 ID Kit: The world's first point-of-care genetic test to reduce the risk of aminoglycoside induced hearing loss
Genedrive was founded on contract research services for pharmaceutical and biotech companies, and was originally named Epistem Holdings Inc. when it was floated on the London AIM market in 2007. The company was renamed genedrive plc in 2016 to reflect its new focus on molecular diagnostics, and divested its contract research services divisions in 2018.
GDR share price launched at 129p in 2007.
Latest directors dealings
- 7 hours ago Origin Enterprises (CDI)
- 7 hours ago Origin Enterprises (CDI)
- 8 hours ago SSP Group
- 8 hours ago Latham (James)
- 9 hours ago LSL Property Services